globalen
Risk Parity versus Mean-Variance: It’s all in the Views

Risk Parity versus Mean-Variance: It’s all in the Views

27-11-2017 | Research

Abstract

The key problem in portfolio optimization is not per se the optimization itself, but the specification of the inputs, notably the views on ex-ante risk premia. The authors add to the literature on portfolio optimization by proposing a portfolio selection framework that allows an investor to position herself between a risk parity strategy and a mean-variance optimized portfolio. Depending on the confidence in one’s risk premium estimates, the optimal portfolio will be tilted more towards one or the other. The authors bridge the gap between risk premium ignorance of risk parity on the one hand, and risk premium clairvoyance of mean-variance on the other hand. The framework is illustrated for a US investor whose opportunity set consists of equities, bonds and commodities.

Stay informed on Quant investing with monthly mail updates
Stay informed on Quant investing with monthly mail updates
Subscribe

Download the research paper

Disclaimer:

This report is not available for users from countries where the offering of foreign financial services is not permitted, such as US Persons.

Your details are not shared with third parties. This information is exclusively intended for professional investors. All requests are checked.

Subjects related to this article are:

Disclaimer

Neither information nor any opinion expressed on the website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports, which can be all be obtained free of charge at this website and at the Robeco offices in each country where Robeco has a presence.

Please confirm that you are a professional investor and/or institutional investor and that you have read, understood and accept the terms of use for this website.

I Disagree